Michael Kagan

Michael Kagan is a Senior Global Clinical Trial Leader at Genentech, where they leverage broad therapeutic experience in international interventional and non-interventional studies, particularly in Oncology, Anti-microbial, and Pain management. With a strong background in vendor management and site oversight, Michael has authored and reviewed essential study documents while maintaining compliance with ICH, GCP, and FDA regulations. They have previously held various roles in clinical study management and regulatory affairs across several prominent organizations, including Gritstone Oncology and Exelixis. Michael holds a B.S. in Biological Sciences from the University of California, Davis, and is pursuing a certificate in Project and Program Management from the University of California, Santa Cruz.